BIOAF(BIOAF)
BIOAF
No analyst ratings available
No analyst price targets available for BIOAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 | $269,880 |
| Low | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 | $269,880 |
| High | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 | $269,880 |
| EBITDA Avg | $-603,153 | $-604,003 | $-1M | $-1M | $-555,854 | $-556,503 | $-557,108 | $-544,112 |
| Low | $-603,153 | $-604,003 | $-1M | $-1M | $-555,854 | $-556,503 | $-557,108 | $-544,112 |
| High | $-603,153 | $-604,003 | $-1M | $-1M | $-555,854 | $-556,503 | $-557,108 | $-544,112 |
| EBIT Avg | $-628,666 | $-628,666 | $-1M | $-1M | $-578,278 | $-578,278 | $-578,278 | $-564,721 |
| Low | $-628,666 | $-628,666 | $-1M | $-1M | $-578,278 | $-578,278 | $-578,278 | $-564,721 |
| High | $-628,666 | $-628,666 | $-1M | $-1M | $-578,278 | $-578,278 | $-578,278 | $-564,721 |
| Net Income Avg | $-858,302 | $-858,302 | $-2M | $-2M | $-807,914 | $-807,914 | $-807,914 | $-794,357 |
| Low | $-858,302 | $-858,302 | $-2M | $-2M | $-807,914 | $-807,914 | $-807,914 | $-794,357 |
| High | $-858,302 | $-858,302 | $-2M | $-2M | $-807,914 | $-807,914 | $-807,914 | $-794,357 |
| EPS Avg | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Low | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| High | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |